Amphastar Pharmaceuticals(us:AMPH)
28.29
-2.41%
Updated on 2025-04-02
Open:28.86
Close:28.29
High:29.27
Low:28.17
Prev Close:28.99
Volume:785073.00
Turnover:22.24M
Turnover Ratio:1.65%
Shares:47.65M
MarketCap:1.35B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 298 | 34353051 | 70.16% | 37 | 99 | 133 |
| 2024-03-31 | 311 | 33515566 | 68.62% | 44 | 86 | 147 |
| 2023-12-31 | 295 | 33301570 | 69.28% | 48 | 96 | 116 |
| 2023-09-30 | 276 | 32093662 | 67.00% | 40 | 89 | 119 |
| 2023-06-30 | 262 | 31375344 | 64.27% | 49 | 79 | 113 |
| 2023-03-31 | 233 | 30139835 | 62.56% | 32 | 72 | 106 |
| 2022-12-31 | 225 | 29115788 | 60.52% | 25 | 69 | 101 |
| 2022-09-30 | 235 | 29830170 | 61.36% | 20 | 80 | 113 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 5942524 | 12.14% | -136518 | -2.25% |
| 2024-06-30 | Vanguard Group Inc | 2672862 | 5.46% | -61178 | -2.24% |
| 2024-06-30 | Federated Hermes, Inc. | 1944800 | 3.97% | -132301 | -6.37% |
| 2024-06-30 | Td Asset Management Inc | 1691569 | 3.45% | 680976 | 67.38% |
| 2024-06-30 | Neuberger Berman Group Llc | 1622609 | 3.31% | -37208 | -2.24% |
| 2024-06-30 | State Street Corp | 1529536 | 3.12% | 15287 | 1.01% |
| 2024-06-30 | Fuller & Thaler Asset Management, Inc. | 1272818 | 2.60% | -1360 | -0.11% |
| 2024-06-30 | Epoch Investment Partners, Inc. | 1078852 | 2.20% | 280390 | 35.12% |
| 2024-06-30 | Dimensional Fund Advisors Lp | 1070275 | 2.19% | -113555 | -9.59% |
| 2024-06-30 | Geode Capital Management, Llc | 906348 | 1.85% | 40316 | 4.66% |
About
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
Address:11570 6th Street
Website:http://www.amphastar.com
Market Movers